Individuals with diabetes preferred that future trials use patient-important outcomes and provide pragmatic inferences.
暂无分享,去创建一个
G. Guyatt | V. Montori | M. Murad | N. Shah | J. Ziegenfuss | Steven A. Smith | T. Beebe | Holly K Van Houten | James R. Deming | Holly K. Van Houten | N. Shah
[1] T. Beebe,et al. Are lower response rates hazardous to your health survey? An analysis of three state telephone health surveys. , 2010, Health services research.
[2] G. Guyatt,et al. A new 'mechanistic-practical" framework for designing and interpreting randomized trials. , 2009, Journal of clinical epidemiology.
[3] Maggie Breslin,et al. The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. , 2008, Patient education and counseling.
[4] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[5] Gordon H Guyatt,et al. Patient-important outcomes in registered diabetes trials. , 2008, JAMA.
[6] Sarah M. Greene,et al. Development and Validation of the Patient Assessment of Chronic Illness Care (PACIC) , 2005, Medical care.
[7] Stanley Presser,et al. Changes in Telephone Survey Nonresponse over the Past Quarter Century , 2005 .
[8] D A Asch,et al. Response rates to mail surveys published in medical journals. , 1997, Journal of clinical epidemiology.
[9] M. Özkaya,et al. Action to Control Cardiovascular Risk in Diabetes , 2013 .
[10] S. Schinner. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .
[11] A. Jakob. Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2008 .
[12] R. Groves. Nonresponse Rates and Nonresponse Bias in Household Surveys , 2006 .